BMRN


Notice: Use of undefined constant MSSQL_BOTH - assumed 'MSSQL_BOTH' in /var/www/api.comtex.com/htdocs/api_db.php on line 43

Notice: Use of undefined constant MSSQL_ASSOC - assumed 'MSSQL_ASSOC' in /var/www/api.comtex.com/htdocs/api_db.php on line 43

Notice: Use of undefined constant MSSQL_NUM - assumed 'MSSQL_NUM' in /var/www/api.comtex.com/htdocs/api_db.php on line 43

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 41

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 42

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 43

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 46

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 47

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 48

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 49

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 50

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 52

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 54

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 55

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 56

Detailed Quote (BMRN)

Last Trade Volume
Change
Change % NA Market Cap.0K
Today's High 52 Week High
Today's Low 52 Week Low
Bid EPS NA
Ask P/E Ratio NA
Open Div. Per Share
Previous Close ExchangeNA

Related News

December 8, 2019

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks...

December 5, 2019

Below are the three companies in the Biotechnology industry with the highest debt to EBITDA ratios. This ratio indicates how many years of EBITDA would be necessary in order to pay back all the debt (assuming Debt and EBITDA are constant)....

December 3, 2019

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

December 3, 2019

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and...

November 25, 2019

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $78.04 to a high of $79.74. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $79.18 on...

November 20, 2019

Below are the three companies in the Biotechnology industry with the highest enterprise value to EBITDA (EV/EBITDA) ratios. EV/EBITDA is an important metric used in valuing comparable companies. It is capital structure neutral and generally the...

November 19, 2019

Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and relative...

November 12, 2019

SmarTrend identified an Uptrend for Biomarin Pharmac (NASDAQ:BMRN) on October 24th, 2019 at $69.90. In approximately 3 weeks, Biomarin Pharmac has returned 9.26% as of today's recent price of $76.37.

Over...

November 9, 2019

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks...

November 6, 2019

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $73.70 to a high of $74.90. Yesterday, the shares gained 10.5%, which took the trading range above the 3-day high of $74.80...